Not a healthcare professional? Go to the patient or caregiver website.

NIVESTYM™ Overdosage (filgrastim-aafi)

10 OVERDOSAGE

The maximum tolerated dose of filgrastim products has not been determined. In filgrastim clinical trials of patients with cancer receiving myelosuppressive chemotherapy‚ WBC counts > 100‚000/mm3 have been reported in less than 5% of patients‚ but were not associated with any reported adverse clinical effects. Patients in the BMT studies received up to 138 mcg/kg/day without toxic effects‚ although there was a flattening of the dose response curve above daily doses of greater than 10 mcg/kg/day.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No